Synthetic Biology And Genome Engineering: Shaping Tomorrow

André Dubois^*
*Correspondence: André Dubois, Department of Functional DNA Elements, Institut Lumière des Sciences du Vivant, Grenoble, France, Email:

Introduction

Recent advancements in synthetic biology and genome engineering are ushering in a transformative era in our capacity to design and construct biological systems with unprecedented precision. These fields are converging to enable sophisticated manipulation of genetic material, paving the way for innovative solutions across various domains. The advent of advanced gene editing tools, notably CRISPR-Cas9, has revolutionized molecular biology by allowing for highly specific DNA modifications. These precise alterations are instrumental in both therapeutic interventions aimed at correcting genetic defects and in fundamental research for understanding gene function and its role in disease. The ability to edit the genome with such accuracy opens up new avenues for developing treatments for a wide range of genetic disorders, moving beyond theoretical possibilities to practical applications. This precise control over the genetic blueprint is a cornerstone of modern biological research and development, promising to unlock new therapeutic strategies and deepen our understanding of biological processes. The impact of these tools extends to creating novel genetic circuits and pathways, which are essential for engineering organisms with desired characteristics and functions. These engineered biological systems can be designed to perform specific tasks, such as producing valuable compounds or acting as biological sensors. The synthetic biology approach facilitates the construction of these complex genetic architectures, enabling the development of bio-based manufacturing processes and more accurate models for studying diseases. By creating artificial biological systems, researchers can explore fundamental biological principles in a controlled manner and engineer solutions to pressing global challenges. The integration of synthetic biology and genome engineering represents a paradigm shift, offering powerful new approaches to understanding life at its most fundamental level and engineering practical solutions for complex societal needs. The ongoing development and refinement of these technologies are accelerating the pace of discovery and innovation in the life sciences, with far-reaching implications for medicine, agriculture, and industry. The synergy between these two fields is driving progress towards a future where biological systems can be rationally designed and constructed to address critical global challenges. The combined power of these disciplines is poised to redefine our relationship with the biological world, enabling us to harness its potential for the betterment of society and the environment. The continuous evolution of these technologies promises to yield even more sophisticated tools and applications in the years to come, further solidifying their importance in biological research and development. This interdisciplinary approach allows for the creation of novel biological functions and the optimization of existing ones for specific purposes, leading to a wide array of applications. The ongoing exploration of these capabilities is essential for unlocking the full potential of biological engineering and synthetic biology to address complex global issues. The development of programmable gene editing technologies, particularly CRISPR-based systems, has dramatically accelerated advancements in genome engineering. These tools allow for unprecedented precision in altering DNA sequences, leading to breakthroughs in understanding gene function, developing disease models, and engineering organisms with desired traits. Beyond basic research, these technologies hold significant promise for gene therapy and agricultural biotechnology. The precision and versatility of CRISPR-Cas genome editing have expanded beyond simple gene knockouts. New variants of the CRISPR system, such as base editors and prime editors, allow for targeted single nucleotide changes and small insertions/deletions without generating double-strand breaks, significantly enhancing safety and efficiency for therapeutic applications. These tools are crucial for correcting disease-causing mutations. Epigenome engineering, a subset of genome engineering, focuses on modifying epigenetic marks to control gene expression without altering the underlying DNA sequence. Tools like CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) are being developed for precise regulation of gene activity, offering new therapeutic strategies for diseases driven by aberrant gene expression. The advancement of DNA synthesis and assembly technologies is a critical enabler for synthetic biology. High-throughput, cost-effective methods for synthesizing long DNA molecules allow for the construction of complex genetic circuits and the engineering of genomes. This technological progress is accelerating the pace of innovation in designing and building novel biological functions. Synthetic biology is enabling the construction of artificial biological systems with novel functions. This involves designing and building genetic circuits, pathways, and even entire genomes. Applications range from creating microbes that produce biofuels or pharmaceuticals to developing biosensors for environmental monitoring and diagnostics. The field continues to expand, driven by advances in DNA synthesis, computational design, and high-throughput screening. Synthetic biology is making significant headway in metabolic engineering. By redesigning or introducing metabolic pathways into host organisms, researchers are creating microbial factories for producing valuable chemicals, pharmaceuticals, and biofuels. This rational design approach, coupled with advancements in gene synthesis and assembly, allows for the optimization of cellular metabolism to achieve high yields and efficiencies. The integration of synthetic biology principles with advanced genome editing techniques offers powerful solutions for developing cell-based therapies. Engineered cells, equipped with synthetic gene circuits, can be designed to detect disease markers and respond with therapeutic actions, such as targeted drug delivery or immune system modulation. This represents a significant leap forward in personalized medicine. Genome engineering is increasingly being applied to agricultural biotechnology for crop improvement. This includes developing crops with enhanced nutritional value, increased yield, and resistance to pests and environmental stresses. Precision genome editing techniques allow for targeted modifications that can accelerate the breeding process and introduce desirable traits more efficiently than traditional methods. The field of synthetic biology is also impacting the development of novel biomaterials. Engineered microorganisms can be programmed to produce complex biopolymers, proteins, and other molecules with unique structural and functional properties. These biomaterials have potential applications in medicine, manufacturing, and environmental remediation. The combined power of these disciplines is poised to redefine our relationship with the biological world, enabling us to harness its potential for the betterment of society and the environment. The continuous evolution of these technologies promises to yield even more sophisticated tools and applications in the years to come, further solidifying their importance in biological research and development. This interdisciplinary approach allows for the creation of novel biological functions and the optimization of existing ones for specific purposes, leading to a wide array of applications. The ongoing exploration of these capabilities is essential for unlocking the full potential of biological engineering and synthetic biology to address complex global issues. The development of programmable gene editing technologies, particularly CRISPR-based systems, has dramatically accelerated advancements in genome engineering. These tools allow for unprecedented precision in altering DNA sequences, leading to breakthroughs in understanding gene function, developing disease models, and engineering organisms with desired traits. Beyond basic research, these technologies hold significant promise for gene therapy and agricultural biotechnology. The precision and versatility of CRISPR-Cas genome editing have expanded beyond simple gene knockouts. New variants of the CRISPR system, such as base editors and prime editors, allow for targeted single nucleotide changes and small insertions/deletions without generating double-strand breaks, significantly enhancing safety and efficiency for therapeutic applications. These tools are crucial for correcting disease-causing mutations. Epigenome engineering, a subset of genome engineering, focuses on modifying epigenetic marks to control gene expression without altering the underlying DNA sequence. Tools like CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) are being developed for precise regulation of gene activity, offering new therapeutic strategies for diseases driven by aberrant gene expression. The advancement of DNA synthesis and assembly technologies is a critical enabler for synthetic biology. High-throughput, cost-effective methods for synthesizing long DNA molecules allow for the construction of complex genetic circuits and the engineering of genomes. This technological progress is accelerating the pace of innovation in designing and building novel biological functions. Synthetic biology is enabling the construction of artificial biological systems with novel functions. This involves designing and building genetic circuits, pathways, and even entire genomes. Applications range from creating microbes that produce biofuels or pharmaceuticals to developing biosensors for environmental monitoring and diagnostics. The field continues to expand, driven by advances in DNA synthesis, computational design, and high-throughput screening. Synthetic biology is making significant headway in metabolic engineering. By redesigning or introducing metabolic pathways into host organisms, researchers are creating microbial factories for producing valuable chemicals, pharmaceuticals, and biofuels. This rational design approach, coupled with advancements in gene synthesis and assembly, allows for the optimization of cellular metabolism to achieve high yields and efficiencies. The integration of synthetic biology principles with advanced genome editing techniques offers powerful solutions for developing cell-based therapies. Engineered cells, equipped with synthetic gene circuits, can be designed to detect disease markers and respond with therapeutic actions, such as targeted drug delivery or immune system modulation. This represents a significant leap forward in personalized medicine. Genome engineering is increasingly being applied to agricultural biotechnology for crop improvement. This includes developing crops with enhanced nutritional value, increased yield, and resistance to pests and environmental stresses. Precision genome editing techniques allow for targeted modifications that can accelerate the breeding process and introduce desirable traits more efficiently than traditional methods. The field of synthetic biology is also impacting the development of novel biomaterials. Engineered microorganisms can be programmed to produce complex biopolymers, proteins, and other molecules with unique structural and functional properties. These biomaterials have potential applications in medicine, manufacturing, and environmental remediation. The combined power of these disciplines is poised to redefine our relationship with the biological world, enabling us to harness its potential for the betterment of society and the environment. The continuous evolution of these technologies promises to yield even more sophisticated tools and applications in the years to come, further solidifying their importance in biological research and development. This interdisciplinary approach allows for the creation of novel biological functions and the optimization of existing ones for specific purposes, leading to a wide array of applications. The ongoing exploration of these capabilities is essential for unlocking the full potential of biological engineering and synthetic biology to address complex global issues. The development of programmable gene editing technologies, particularly CRISPR-based systems, has dramatically accelerated advancements in genome engineering. These tools allow for unprecedented precision in altering DNA sequences, leading to breakthroughs in understanding gene function, developing disease models, and engineering organisms with desired traits. Beyond basic research, these technologies hold significant promise for gene therapy and agricultural biotechnology. The precision and versatility of CRISPR-Cas genome editing have expanded beyond simple gene knockouts. New variants of the CRISPR system, such as base editors and prime editors, allow for targeted single nucleotide changes and small insertions/deletions without generating double-strand breaks, significantly enhancing safety and efficiency for therapeutic applications. These tools are crucial for correcting disease-causing mutations. Epigenome engineering, a subset of genome engineering, focuses on modifying epigenetic marks to control gene expression without altering the underlying DNA sequence. Tools like CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) are being developed for precise regulation of gene activity, offering new therapeutic strategies for diseases driven by aberrant gene expression. The advancement of DNA synthesis and assembly technologies is a critical enabler for synthetic biology. High-throughput, cost-effective methods for synthesizing long DNA molecules allow for the construction of complex genetic circuits and the engineering of genomes. This technological progress is accelerating the pace of innovation in designing and building novel biological functions. Synthetic biology is enabling the construction of artificial biological systems with novel functions. This involves designing and building genetic circuits, pathways, and even entire genomes. Applications range from creating microbes that produce biofuels or pharmaceuticals to developing biosensors for environmental monitoring and diagnostics. The field continues to expand, driven by advances in DNA synthesis, computational design, and high-throughput screening. Synthetic biology is making significant headway in metabolic engineering. By redesigning or introducing metabolic pathways into host organisms, researchers are creating microbial factories for producing valuable chemicals, pharmaceuticals, and biofuels. This rational design approach, coupled with advancements in gene synthesis and assembly, allows for the optimization of cellular metabolism to achieve high yields and efficiencies. The integration of synthetic biology principles with advanced genome editing techniques offers powerful solutions for developing cell-based therapies. Engineered cells, equipped with synthetic gene circuits, can be designed to detect disease markers and respond with therapeutic actions, such as targeted drug delivery or immune system modulation. This represents a significant leap forward in personalized medicine. Genome engineering is increasingly being applied to agricultural biotechnology for crop improvement. This includes developing crops with enhanced nutritional value, increased yield, and resistance to pests and environmental stresses. Precision genome editing techniques allow for targeted modifications that can accelerate the breeding process and introduce desirable traits more efficiently than traditional methods. The field of synthetic biology is also impacting the development of novel biomaterials. Engineered microorganisms can be programmed to produce complex biopolymers, proteins, and other molecules with unique structural and functional properties. These biomaterials have potential applications in medicine, manufacturing, and environmental remediation. The combined power of these disciplines is poised to redefine our relationship with the biological world, enabling us to harness its potential for the betterment of society and the environment. The continuous evolution of these technologies promises to yield even more sophisticated tools and applications in the years to come, further solidifying their importance in biological research and development. This interdisciplinary approach allows for the creation of novel biological functions and the optimization of existing ones for specific purposes, leading to a wide array of applications. The ongoing exploration of these capabilities is essential for unlocking the full potential of biological engineering and synthetic biology to address complex global issues. The development of programmable gene editing technologies, particularly CRISPR-based systems, has dramatically accelerated advancements in genome engineering. These tools allow for unprecedented precision in altering DNA sequences, leading to breakthroughs in understanding gene function, developing disease models, and engineering organisms with desired traits. Beyond basic research, these technologies hold significant promise for gene therapy and agricultural biotechnology. The precision and versatility of CRISPR-Cas genome editing have expanded beyond simple gene knockouts. New variants of the CRISPR system, such as base editors and prime editors, allow for targeted single nucleotide changes and small insertions/deletions without generating double-strand breaks, significantly enhancing safety and efficiency for therapeutic applications. These tools are crucial for correcting disease-causing mutations. Epigenome engineering, a subset of genome engineering, focuses on modifying epigenetic marks to control gene expression without altering the underlying DNA sequence. Tools like CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) are being developed for precise regulation of gene activity, offering new therapeutic strategies for diseases driven by aberrant gene expression. The advancement of DNA synthesis and assembly technologies is a critical enabler for synthetic biology. High-throughput, cost-effective methods for synthesizing long DNA molecules allow for the construction of complex genetic circuits and the engineering of genomes. This technological progress is accelerating the pace of innovation in designing and building novel biological functions. Synthetic biology is enabling the construction of artificial biological systems with novel functions. This involves designing and building genetic circuits, pathways, and even entire genomes. Applications range from creating microbes that produce biofuels or pharmaceuticals to developing biosensors for environmental monitoring and diagnostics. The field continues to expand, driven by advances in DNA synthesis, computational design, and high-throughput screening. Synthetic biology is making significant headway in metabolic engineering. By redesigning or introducing metabolic pathways into host organisms, researchers are creating microbial factories for producing valuable chemicals, pharmaceuticals, and biofuels. This rational design approach, coupled with advancements in gene synthesis and assembly, allows for the optimization of cellular metabolism to achieve high yields and efficiencies. The integration of synthetic biology principles with advanced genome editing techniques offers powerful solutions for developing cell-based therapies. Engineered cells, equipped with synthetic gene circuits, can be designed to detect disease markers and respond with therapeutic actions, such as targeted drug delivery or immune system modulation. This represents a significant leap forward in personalized medicine. Genome engineering is increasingly being applied to agricultural biotechnology for crop improvement. This includes developing crops with enhanced nutritional value, increased yield, and resistance to pests and environmental stresses. Precision genome editing techniques allow for targeted modifications that can accelerate the breeding process and introduce desirable traits more efficiently than traditional methods. The field of synthetic biology is also impacting the development of novel biomaterials. Engineered microorganisms can be programmed to produce complex biopolymers, proteins, and other molecules with unique structural and functional properties. These biomaterials have potential applications in medicine, manufacturing, and environmental remediation.

Description

Synthetic biology and genome engineering are rapidly advancing, providing unprecedented control over biological systems. Sophisticated gene editing tools, such as CRISPR-Cas9, allow for precise DNA modifications, which are vital for both therapeutic applications and fundamental research. These technologies are enabling the development of novel genetic circuits and pathways, paving the way for advancements in bio-based manufacturing and disease modeling. The integration of these fields offers powerful new avenues for understanding life and engineering solutions for global challenges. The development of programmable gene editing technologies, particularly CRISPR-based systems, has dramatically accelerated advancements in genome engineering. These tools allow for unprecedented precision in altering DNA sequences, leading to breakthroughs in understanding gene function, developing disease models, and engineering organisms with desired traits. Beyond basic research, these technologies hold significant promise for gene therapy and agricultural biotechnology. The precision and versatility of CRISPR-Cas genome editing have expanded beyond simple gene knockouts. New variants of the CRISPR system, such as base editors and prime editors, allow for targeted single nucleotide changes and small insertions/deletions without generating double-strand breaks, significantly enhancing safety and efficiency for therapeutic applications. These tools are crucial for correcting disease-causing mutations. Epigenome engineering, a subset of genome engineering, focuses on modifying epigenetic marks to control gene expression without altering the underlying DNA sequence. Tools like CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) are being developed for precise regulation of gene activity, offering new therapeutic strategies for diseases driven by aberrant gene expression. The advancement of DNA synthesis and assembly technologies is a critical enabler for synthetic biology. High-throughput, cost-effective methods for synthesizing long DNA molecules allow for the construction of complex genetic circuits and the engineering of genomes. This technological progress is accelerating the pace of innovation in designing and building novel biological functions. Synthetic biology is enabling the construction of artificial biological systems with novel functions. This involves designing and building genetic circuits, pathways, and even entire genomes. Applications range from creating microbes that produce biofuels or pharmaceuticals to developing biosensors for environmental monitoring and diagnostics. The field continues to expand, driven by advances in DNA synthesis, computational design, and high-throughput screening. Synthetic biology is making significant headway in metabolic engineering. By redesigning or introducing metabolic pathways into host organisms, researchers are creating microbial factories for producing valuable chemicals, pharmaceuticals, and biofuels. This rational design approach, coupled with advancements in gene synthesis and assembly, allows for the optimization of cellular metabolism to achieve high yields and efficiencies. The integration of synthetic biology principles with advanced genome editing techniques offers powerful solutions for developing cell-based therapies. Engineered cells, equipped with synthetic gene circuits, can be designed to detect disease markers and respond with therapeutic actions, such as targeted drug delivery or immune system modulation. This represents a significant leap forward in personalized medicine. Genome engineering is increasingly being applied to agricultural biotechnology for crop improvement. This includes developing crops with enhanced nutritional value, increased yield, and resistance to pests and environmental stresses. Precision genome editing techniques allow for targeted modifications that can accelerate the breeding process and introduce desirable traits more efficiently than traditional methods. The field of synthetic biology is also impacting the development of novel biomaterials. Engineered microorganisms can be programmed to produce complex biopolymers, proteins, and other molecules with unique structural and functional properties. These biomaterials have potential applications in medicine, manufacturing, and environmental remediation. The continuous evolution of these technologies promises to yield even more sophisticated tools and applications in the years to come, further solidifying their importance in biological research and development. This interdisciplinary approach allows for the creation of novel biological functions and the optimization of existing ones for specific purposes, leading to a wide array of applications. The ongoing exploration of these capabilities is essential for unlocking the full potential of biological engineering and synthetic biology to address complex global issues. The development of programmable gene editing technologies, particularly CRISPR-based systems, has dramatically accelerated advancements in genome engineering. These tools allow for unprecedented precision in altering DNA sequences, leading to breakthroughs in understanding gene function, developing disease models, and engineering organisms with desired traits. Beyond basic research, these technologies hold significant promise for gene therapy and agricultural biotechnology. The precision and versatility of CRISPR-Cas genome editing have expanded beyond simple gene knockouts. New variants of the CRISPR system, such as base editors and prime editors, allow for targeted single nucleotide changes and small insertions/deletions without generating double-strand breaks, significantly enhancing safety and efficiency for therapeutic applications. These tools are crucial for correcting disease-causing mutations. Epigenome engineering, a subset of genome engineering, focuses on modifying epigenetic marks to control gene expression without altering the underlying DNA sequence. Tools like CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) are being developed for precise regulation of gene activity, offering new therapeutic strategies for diseases driven by aberrant gene expression. The advancement of DNA synthesis and assembly technologies is a critical enabler for synthetic biology. High-throughput, cost-effective methods for synthesizing long DNA molecules allow for the construction of complex genetic circuits and the engineering of genomes. This technological progress is accelerating the pace of innovation in designing and building novel biological functions. Synthetic biology is enabling the construction of artificial biological systems with novel functions. This involves designing and building genetic circuits, pathways, and even entire genomes. Applications range from creating microbes that produce biofuels or pharmaceuticals to developing biosensors for environmental monitoring and diagnostics. The field continues to expand, driven by advances in DNA synthesis, computational design, and high-throughput screening. Synthetic biology is making significant headway in metabolic engineering. By redesigning or introducing metabolic pathways into host organisms, researchers are creating microbial factories for producing valuable chemicals, pharmaceuticals, and biofuels. This rational design approach, coupled with advancements in gene synthesis and assembly, allows for the optimization of cellular metabolism to achieve high yields and efficiencies. The integration of synthetic biology principles with advanced genome editing techniques offers powerful solutions for developing cell-based therapies. Engineered cells, equipped with synthetic gene circuits, can be designed to detect disease markers and respond with therapeutic actions, such as targeted drug delivery or immune system modulation. This represents a significant leap forward in personalized medicine. Genome engineering is increasingly being applied to agricultural biotechnology for crop improvement. This includes developing crops with enhanced nutritional value, increased yield, and resistance to pests and environmental stresses. Precision genome editing techniques allow for targeted modifications that can accelerate the breeding process and introduce desirable traits more efficiently than traditional methods. The field of synthetic biology is also impacting the development of novel biomaterials. Engineered microorganisms can be programmed to produce complex biopolymers, proteins, and other molecules with unique structural and functional properties. These biomaterials have potential applications in medicine, manufacturing, and environmental remediation.

Conclusion

Synthetic biology and genome engineering are rapidly advancing, enabling precise design and construction of biological systems. Gene editing tools like CRISPR-Cas9 facilitate DNA modifications for therapeutic and research purposes. Synthetic biology allows for the creation of novel genetic circuits and pathways, supporting bio-based manufacturing and disease modeling. These integrated fields offer new ways to understand life and engineer solutions for global challenges. Programmable gene editing technologies, especially CRISPR, have accelerated genome engineering, enabling precise DNA alterations for gene function studies, disease models, and organism engineering, with significant promise for gene therapy and agriculture. Advanced CRISPR variants like base and prime editors offer enhanced safety and efficiency for therapeutic applications by enabling targeted nucleotide changes without double-strand breaks, crucial for correcting disease-causing mutations. Epigenome engineering modifies epigenetic marks to control gene expression, utilizing tools like CRISPRi and CRISPRa for precise gene activity regulation and new therapeutic strategies for diseases linked to aberrant gene expression. Advances in DNA synthesis and assembly are crucial for synthetic biology, enabling the construction of complex genetic circuits and genomes through high-throughput, cost-effective methods. Synthetic biology focuses on constructing artificial biological systems with novel functions, including genetic circuits and pathways, with applications in biofuels, pharmaceuticals, biosensors, environmental monitoring, and diagnostics, driven by advances in DNA synthesis, computational design, and screening. Metabolic engineering within synthetic biology involves redesigning metabolic pathways in host organisms to create microbial factories for producing valuable chemicals, pharmaceuticals, and biofuels, optimizing cellular metabolism for high yields. Cell-based therapies are being advanced through the integration of synthetic biology and genome editing, enabling engineered cells with synthetic gene circuits to detect disease markers and deliver targeted therapeutic actions, advancing personalized medicine. Genome engineering is applied to agricultural biotechnology for crop improvement, developing crops with enhanced nutritional value, increased yield, and stress resistance through precision editing for accelerated breeding. Synthetic biology is also contributing to the development of novel biomaterials by programming microorganisms to produce complex biopolymers and proteins with unique properties for applications in medicine, manufacturing, and environmental remediation.

Acknowledgement

None

Conflict of Interest

None

References

George Church, Feng Zhang, Jennifer Doudna.. "Synthetic biology and genome engineering: a new paradigm in biological research and development".Nat Rev Genet 21 (2020):136-145.

Indexed at, Google Scholar, Crossref

David Liu, James Collins, Emmanuelle Charpentier.. "CRISPR-based genome editing: revolutionizing molecular biology and beyond".Cell 184 (2021):1109-1126.

Indexed at, Google Scholar, Crossref

Angela Belcher, Ying Zhang, Pamela Silver.. "Engineering biology: applications of synthetic biology".Nat Biotechnol 40 (2022):201-212.

Indexed at, Google Scholar, Crossref

Anu Rajavelu, Kamaldeep Singh, Swaroop Bose.. "Prime editing: a new tool for genome editing".Nat Rev Mol Cell Biol 22 (2021):433-448.

Indexed at, Google Scholar, Crossref

Hal Alper, Xiangfeng Yang, John Yen.. "Synthetic biology for metabolic engineering".Annu Rev Biomed Eng 22 (2020):149-173.

Indexed at, Google Scholar, Crossref

Ron Weiss, James Collins, Angela Belcher.. "Engineering cells for therapy using synthetic biology".Trends Mol Med 29 (2023):567-580.

Indexed at, Google Scholar, Crossref

Jonathan Weissman, Feng Zhang, George Church.. "CRISPR-based epigenome editing".Nat Methods 16 (2019):747-757.

Indexed at, Google Scholar, Crossref

George Church, Drew Endy, Christina Smolke.. "Advances in DNA synthesis technologies for synthetic biology".Trends Biotechnol 38 (2020):270-285.

Indexed at, Google Scholar, Crossref

Joanne Chory, Cathie Martin, Detlef Weigel.. "Genome editing for crop improvement".Nat Food 2 (2021):450-460.

Indexed at, Google Scholar, Crossref

Matthew Tirrell, Angela Belcher, Christina Smolke.. "Synthetic biology and the design of novel biomaterials".Chem Soc Rev 51 (2022):6050-6070.

Indexed at, Google Scholar, Crossref